Maja Magdalena Kaczmarek
InvestorVenture Fellow (2023 Class) at LongeVC
About
Kaczmarek's research focuses on optimizing ex vivo machine perfusion conditions to preserve metabolism and mitochondrial function in human kidneys for transplantation, using techniques including qPCR, ELISA, RNAseq, and mass-spectrometry. She holds a B.Sc. in Biomedical Sciences from the University of Manchester and previously worked on improving remyelination with CRISPR-edited human ES-derived oligodendrocyte progenitor cells during a placement year at the University of Edinburgh. She serves as Vice-President of the Cambridge Society of Ageing and Longevity Research and participates in the University of Cambridge iTeams programme, working on commercializing a material for in vivo detection of senescent cells.
Contact· self-published, not guessed
Invests in
BiotechLongevity
Colleagues at LongeVC
Frequently asked questions
- Who is Maja Magdalena Kaczmarek?
- Kaczmarek's research focuses on optimizing ex vivo machine perfusion conditions to preserve metabolism and mitochondrial function in human kidneys for transplantation, using techniques including qPCR, ELISA, RNAseq, and mass-spectrometry. She holds a B.Sc. in Biomedical Sciences from the University of Manchester and previously worked on improving remyelination with CRISPR-edited human ES-derived oligodendrocyte progenitor cells during a placement year at the University of Edinburgh. She serves as Vice-President of the Cambridge Society of Ageing and Longevity Research and participates in the University of Cambridge iTeams programme, working on commercializing a material for in vivo detection of senescent cells.
- Where does Maja Magdalena Kaczmarek work?
- Maja Magdalena Kaczmarek is Venture Fellow (2023 Class) at LongeVC.
- What does Maja Magdalena Kaczmarek invest in?
- Maja Magdalena Kaczmarek invests in Biotech, Longevity.